Clinical Research Directory
Browse clinical research sites, groups, and studies.
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients
Sponsor: ViiV Healthcare
Summary
The purpose of this study is to determine whether the BMS Attachment Inhibitor (BMS-663068) is effective in the treatment of heavily treatment experienced HIV-1 patients with multi-drug resistance.
Official title: A Multi-arm, Phase 3, Randomized, Placebo Controlled, Double Blind Clinical Trial to Investigate the Efficacy and Safety of Fostemsavir (BMS-663068/GSK3684934) in Heavily Treatment Experienced Subjects Infected With Multi-drug Resistant HIV-1 (BRIGHTE Study)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
371
Start Date
2015-02-23
Completion Date
2026-09-30
Last Updated
2025-08-22
Healthy Volunteers
No
Conditions
Interventions
BMS-663068
BMS-663068
Placebo
Placebo
Locations (139)
GSK Investigational Site
Los Angeles, California, United States
GSK Investigational Site
Los Angeles, California, United States
GSK Investigational Site
Los Angeles, California, United States
GSK Investigational Site
Los Angeles, California, United States
GSK Investigational Site
Palm Springs, California, United States
GSK Investigational Site
San Francisco, California, United States
GSK Investigational Site
Denver, Colorado, United States
GSK Investigational Site
New Haven, Connecticut, United States
GSK Investigational Site
Washington D.C., District of Columbia, United States
GSK Investigational Site
Washington D.C., District of Columbia, United States
GSK Investigational Site
Ft. Pierce, Florida, United States
GSK Investigational Site
Orlando, Florida, United States
GSK Investigational Site
West Palm Beach, Florida, United States
GSK Investigational Site
Wilton Manors, Florida, United States
GSK Investigational Site
Atlanta, Georgia, United States
GSK Investigational Site
Atlanta, Georgia, United States
GSK Investigational Site
Savannah, Georgia, United States
GSK Investigational Site
Chicago, Illinois, United States
GSK Investigational Site
Chicago, Illinois, United States
GSK Investigational Site
Indianapolis, Indiana, United States
GSK Investigational Site
Baltimore, Maryland, United States
GSK Investigational Site
Baltimore, Maryland, United States
GSK Investigational Site
Boston, Massachusetts, United States
GSK Investigational Site
Southfield, Michigan, United States
GSK Investigational Site
Hillsborough, New Jersey, United States
GSK Investigational Site
Newark, New Jersey, United States
GSK Investigational Site
Manhasset, New York, United States
GSK Investigational Site
New York, New York, United States
GSK Investigational Site
New York, New York, United States
GSK Investigational Site
The Bronx, New York, United States
GSK Investigational Site
Chapel Hill, North Carolina, United States
GSK Investigational Site
Durham, North Carolina, United States
GSK Investigational Site
Cincinnati, Ohio, United States
GSK Investigational Site
Tulsa, Oklahoma, United States
GSK Investigational Site
Philadelphia, Pennsylvania, United States
GSK Investigational Site
Bellaire, Texas, United States
GSK Investigational Site
Dallas, Texas, United States
GSK Investigational Site
Dallas, Texas, United States
GSK Investigational Site
Houston, Texas, United States
GSK Investigational Site
Buenos Aires, Argentina
GSK Investigational Site
Buenos Aires, Argentina
GSK Investigational Site
Buenos Aires, Argentina
GSK Investigational Site
Ciudad Autonoma de Buenos Aire, Argentina
GSK Investigational Site
Ciudad Autonoma de Bueno, Argentina
GSK Investigational Site
Córdoba, Argentina
GSK Investigational Site
Córdoba, Argentina
GSK Investigational Site
Rosario, Argentina
GSK Investigational Site
Darlinghurst, New South Wales, Australia
GSK Investigational Site
Melbourne, Victoria, Australia
GSK Investigational Site
Antwerp, Belgium
GSK Investigational Site
Brussels, Belgium
GSK Investigational Site
Belo Horizonte, Brazil
GSK Investigational Site
Campinas, Brazil
GSK Investigational Site
Curitiba, Brazil
GSK Investigational Site
Porto Alegre, Brazil
GSK Investigational Site
RibeirAo PretoSP, Brazil
GSK Investigational Site
Rio de Janeiro, Brazil
GSK Investigational Site
Salvador, Brazil
GSK Investigational Site
São Paulo, Brazil
GSK Investigational Site
São Paulo, Brazil
GSK Investigational Site
São Paulo, Brazil
GSK Investigational Site
Vancouver, British Columbia, Canada
GSK Investigational Site
Vancouver, British Columbia, Canada
GSK Investigational Site
Ottawa, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Montreal, Quebec, Canada
GSK Investigational Site
Montreal, Quebec, Canada
GSK Investigational Site
Sainte-Foy, Quebec, Canada
GSK Investigational Site
Santiago, Chile
GSK Investigational Site
Santiago, Chile
GSK Investigational Site
Santiago, Chile
GSK Investigational Site
Santiago, Chile
GSK Investigational Site
Temuco, Chile
GSK Investigational Site
Bogotá, Colombia
GSK Investigational Site
Bogotá, Colombia
GSK Investigational Site
Cali, Colombia
GSK Investigational Site
Bordeaux, France
GSK Investigational Site
Marseille, France
GSK Investigational Site
Nantes, France
GSK Investigational Site
Paris, France
GSK Investigational Site
Paris, France
GSK Investigational Site
Paris, France
GSK Investigational Site
Paris, France
GSK Investigational Site
Paris, France
GSK Investigational Site
Paris, France
GSK Investigational Site
Berlin, Germany
GSK Investigational Site
Berlin, Germany
GSK Investigational Site
Berlin, Germany
GSK Investigational Site
Dortmund, Germany
GSK Investigational Site
Frankfurt, Germany
GSK Investigational Site
Freiburg im Breisgau, Germany
GSK Investigational Site
München, Germany
GSK Investigational Site
Athens, Greece
GSK Investigational Site
Thessaloniki, Greece
GSK Investigational Site
Dublin, Ireland
GSK Investigational Site
Milan, Italy
GSK Investigational Site
Milan, Italy
GSK Investigational Site
Modena, Italy
GSK Investigational Site
Monza MB, Italy
GSK Investigational Site
Roma, Italy
GSK Investigational Site
Roma, Italy
GSK Investigational Site
Torino, Italy
GSK Investigational Site
Chihuahua City, Mexico
GSK Investigational Site
Distrito Federal, Mexico
GSK Investigational Site
Distrito Federal, Mexico
GSK Investigational Site
Guadalajara, Mexico
GSK Investigational Site
Mexico City, Mexico
GSK Investigational Site
México, Mexico
GSK Investigational Site
Utrecht, Netherlands
GSK Investigational Site
Iquitos, Peru
GSK Investigational Site
Lima, Peru
GSK Investigational Site
Lima, Peru
GSK Investigational Site
Lima, Peru
GSK Investigational Site
Lima, Peru
GSK Investigational Site
Szczecin, Poland
GSK Investigational Site
Warsaw, Poland
GSK Investigational Site
Lisbon, Portugal
GSK Investigational Site
Lisbon, Portugal
GSK Investigational Site
San Juan, Puerto Rico
GSK Investigational Site
Bucharest, Romania
GSK Investigational Site
Constanța, Romania
GSK Investigational Site
Irkutsk, Russia
GSK Investigational Site
Krasnodar, Russia
GSK Investigational Site
Auckland Park Johannesb, South Africa
GSK Investigational Site
Benoni, South Africa
GSK Investigational Site
Bloemfontein, South Africa
GSK Investigational Site
Cape Town, South Africa
GSK Investigational Site
Dundee, South Africa
GSK Investigational Site
Durban, South Africa
GSK Investigational Site
Observatory Cape Town, South Africa
GSK Investigational Site
Port Elizabeth, South Africa
GSK Investigational Site
Badalona, Spain
GSK Investigational Site
Barcelona, Spain
GSK Investigational Site
Madrid, Spain
GSK Investigational Site
Seville, Spain
GSK Investigational Site
Taipei, Taiwan
GSK Investigational Site
Bournemouth, United Kingdom
GSK Investigational Site
Leicester, United Kingdom
GSK Investigational Site
London, United Kingdom